Delivery Order SPE2DB22D3401-SPE2DB24FT2EF

Award Date 3/11/24
Potential Completion Date 3/12/24
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $3,080.04 firm fixed-price contract has an ultimate completion date of August 26, 2024 and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will deliver the medical supplies to support various federal healthcare programs and facilities,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $31,405.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $24,443.70 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order contract is issued under...
This is a $1,629.58 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a specialty pharmaceutical product, with a completion date of January 29, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds an...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $12,110.08 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a performance period through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a potential value of $6,518.32 and a completion date of January 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.08, is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a medical product, with a performance period ending on January 15, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $33,086.88 and a period of performance through April 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGE/ML pharmaceutical products. The $1,552.08 award has a performance period through February 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,629.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which was not set aside for any specific business type. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT2EF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,921,977 units of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $1,588.50 contract has an ultimate completion date of March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside was used for this contract award.

Generated 6/10/24, 9:03 AM